Document Detail


Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm.
MedLine Citation:
PMID:  12745015     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Several aminocarboxylate complexes of the "no carrier added" (NCA) radiolanthanides (149)Pm, (166)Ho and (177)Lu were evaluated using our in vitro hydroxyapatite and serum stability model and in vivo in normal CF-1 mice [10]. The aminocarboxylate chelates evaluated with the NCA radiolanthanides for in vitro stability were EDTA, CDTA, DTPA, MA-DTPA and DOTA. In addition, the NCA radiolanthanide complexes with DTPA-octreotide (DTPA-OCT) were synthesized and evaluated, as a model for a peptide conjugated aminocarboxylate complex. The biodistribution studies of the NCA complexes with DTPA, DOTA and DTPA-OCT showed that the in vitro model correctly predicted the in vivo stability of the radiolanthanide complexes, with Ln-DOTA > Ln-DTPA > Ln-DTPA-OCT.
Authors:
Wen Ping Li; C Jeff Smith; Cathy S Cutler; Timothy J Hoffman; Alan R Ketring; Silvia S Jurisson
Related Documents :
21893735 - Towards an interoperable information infrastructure providing decision support for geno...
3334025 - Boxing injuries: neurologic, radiologic, and neuropsychologic evaluation.
2346545 - Evaluation of skin irritation and contact sensitizing potential of fenticonazole.
17295385 - Shilajit: a review.
11999785 - First world-wide interlaboratory study on polybrominated diphenylethers (pbdes).
9834695 - Educating future physicians for ontario.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nuclear medicine and biology     Volume:  30     ISSN:  0969-8051     ISO Abbreviation:  Nucl. Med. Biol.     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-05-14     Completed Date:  2003-09-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9304420     Medline TA:  Nucl Med Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  241-51     Citation Subset:  IM    
Affiliation:
Department of Chemistry, University of Missouri, Columbia, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chelating Agents / pharmacology
Drug Stability
Half-Life
Holmium / blood,  chemistry,  pharmacokinetics
Humans
Lutetium / blood,  chemistry,  pharmacokinetics
Mice
Octreotide / blood,  chemistry*,  pharmacokinetics
Promethium / blood,  chemistry,  pharmacokinetics
Radioisotopes / blood,  chemistry*,  pharmacokinetics
Radiopharmaceuticals / blood,  chemistry*,  pharmacokinetics
Tissue Distribution
Chemical
Reg. No./Substance:
0/Chelating Agents; 0/Radioisotopes; 0/Radiopharmaceuticals; 7439-94-3/Lutetium; 7440-12-2/Promethium; 7440-60-0/Holmium; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Determination of [18F]FCWAY, [18F]FP-TZTP, and their metabolites in plasma using rapid and efficient...
Next Document:  Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount inje...